Malle Jurima-Romet, Ph.D.
Dr. Jurima-Romet has 25 years of biomedical and pharmaceutical research experience, with a focus on drug metabolism. She earned her Ph.D. in pharmacology from the University of Toronto where her doctoral research was in the field of pharmacogenetics. As a research scientist with the Therapeutic Products Directorate in Ottawa from 1989 – 1998, Dr. Jurima-Romet established a research program in drug metabolism, focusing on drug-drug interactions, mechanisms of drug-induced hepatotoxicity, and pharmacogenetics in unique Canadian populations. With an extensive background in drug metabolism, Dr. Jurima-Romet provides invaluable insight to pharmaceutical and biotechnology clients on the critical role of metabolism in their non-clinical and clinical drug development programs. Prior to joining Celerion, Dr. Jurima-Romet served as director of the In Vitro Metabolism and Cell-Based Assays department with MDS Pharma Services.
Dr. Jurima-Romet is a member of the Board of Directors with American Society for Clinical Pharmacology and Therapeutics (ASCPT). She has focused attention on the importance of MIST for clinical pharmacology by organizing a workshop on MIST at the 2012 ASCPT Annual Meeting, Dr. Jurima-Romet has also organized numerous symposia on drug metabolism related topics for the International Society for the Study of Xenobiotics (ISSX) where she is currently on the organizing committee for the 10th International ISSX Meeting.
As Senior Director of Drug Development at Celerion, Dr. Jurima-Romet leads drug development program teams, and provides strategic and scientific consulting to pharmaceutical and biotechnology clients. Since assuming this role in 2003, she has led the successful development of several pre-clinical candidate compounds through IND-enabling preclinical studies into Phase I and II clinical trials.
She has authored over 60 peer-reviewed publications, and co-edited books on biomarkers in drug development and drug-drug interactions. She has given numerous invited lectures at scientific meetings and academic institutions, and previously was an adjunct professor at the University of Montreal and at the University of Ottawa.